A trial finds a liberal vs restrictive transfusion threshold for at-risk cardiac patients may improve heart failure and ...

Dr S. Shahzad Mustafa highlights new systemic therapies for urticaria, their impact on quality of life, and the need for ways ...

A new WHO study finds that telemedicine initiatives improve psychological well-being and quality of life among patients with ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

A simulation study suggests that routine use of multicancer early detection tests could cut stage IV diagnoses of 14 cancers ...

Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...

The EMA’s assessment confirms the treatment matches the reference drug in quality and performance, potentially expanding ...

The recommendation follows results showing markedly longer time to diagnosis of stage 3 T1D in treated patients, a condition ...

Avian flu in humans may have made a reappearance after 9 months, according to a press release from the Washington State Department of Health.

Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...

The regulator backed the medicine after phase 3 data showed dramatic reductions in HAE attacks and sustained disease control over 6 months.

Myocardial infarction is significantly associated with the development of epilepsy and nonstroke vascular death in older adults, new research shows.